Single-Surgeon Experience for Maximizing Outcomes in Implant-Based Breast Reconstruction in Chinese Patients

医学 乳房再造术 包膜挛缩 植入 乳房切除术 患者满意度 外科 乳房整形术 回顾性队列研究 乳腺癌 癌症 内科学
作者
Shanshan He,Jian Yin,Jingyan Sun,Qingfeng Huang,Jing Liu,Chunyong Han,Zhuming Yin
出处
期刊:Annals of Plastic Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:82 (3): 269-273 被引量:5
标识
DOI:10.1097/sap.0000000000001645
摘要

Breast reconstruction for Chinese patients is vastly different given cultural differences, patient preferences, access to resources, and insurance coverage in China. Given these unique factors, a different approach for optimizing outcomes should be considered.Retrospective review of all patients undergoing implant-based breast reconstruction from January 2013 to May 2016 was performed. Esthetic evaluations were made both by the patients and 1 nonoperative surgeon at least 6 months postoperative, and patient satisfaction was assessed using the Breast-Q.Overall, 135 patients undergoing 141 implant-based breast reconstructions were reviewed. The majority of implants (n = 134) were placed in a subpectoral position, whereas 7 were placed prepectorally, and no acellular dermal matrix was used. Given the limitations in acellular dermal matrix usage, soft-tissue coverage was augmented with local regional flaps. Ninety-four reconstructions (66.7%) used latissimus dorsi, 39 (27.7%) used serratus anterior, and 7 (5.0%) used mastectomy skin flaps only for implant coverage. Four patients (2.8%) underwent revision surgery to the reconstructed breasts. Grade III and grade IV capsular contracture was observed in 10 (7.1%) and 2 (1.4%) reconstructions, respectively. Both the patient's and the surgeon's satisfaction were higher than 80% in breast symmetry.Our implant selection method fit the Chinese population characteristics and could be extended to different types of implant-based breast reconstruction. It produced good esthetic outcomes and was reproducible, predictable, and simple to master in the clinical setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
愤怒的水绿完成签到,获得积分10
刚刚
倪妮完成签到 ,获得积分10
1秒前
MaxwellZH完成签到,获得积分10
1秒前
maybe完成签到,获得积分10
1秒前
Vanda完成签到,获得积分10
2秒前
666星爷完成签到,获得积分10
2秒前
eternal_dreams完成签到 ,获得积分10
2秒前
surlamper完成签到,获得积分10
2秒前
sheep完成签到,获得积分10
3秒前
205完成签到,获得积分10
3秒前
茴香豆完成签到,获得积分10
3秒前
hahaha2完成签到,获得积分10
3秒前
cl完成签到,获得积分10
3秒前
徐彬荣完成签到,获得积分10
4秒前
4秒前
Tom2077完成签到,获得积分10
5秒前
霡霂完成签到,获得积分10
5秒前
LGA1700完成签到,获得积分10
6秒前
Walton完成签到,获得积分10
6秒前
量子咸鱼K完成签到,获得积分10
6秒前
fate完成签到,获得积分10
6秒前
PaperCrane完成签到,获得积分10
6秒前
6秒前
清风徐来完成签到,获得积分10
7秒前
九月应助科研通管家采纳,获得10
7秒前
hahaha1完成签到,获得积分10
7秒前
7秒前
彭于晏应助科研通管家采纳,获得10
7秒前
wanci应助科研通管家采纳,获得30
7秒前
7秒前
英俊的铭应助科研通管家采纳,获得10
7秒前
在水一方应助科研通管家采纳,获得10
7秒前
明阳发布了新的文献求助10
7秒前
Orange应助科研通管家采纳,获得10
7秒前
慕青应助科研通管家采纳,获得10
7秒前
9秒前
独特的秋完成签到,获得积分10
15秒前
xiaoyi发布了新的文献求助10
15秒前
接accept完成签到 ,获得积分10
17秒前
Glitter完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Feldspar inclusion dating of ceramics and burnt stones 1000
The Psychological Quest for Meaning 800
What is the Future of Psychotherapy in a Digital Age? 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5958588
求助须知:如何正确求助?哪些是违规求助? 7197336
关于积分的说明 15947853
捐赠科研通 5094492
什么是DOI,文献DOI怎么找? 2737707
邀请新用户注册赠送积分活动 1699379
关于科研通互助平台的介绍 1618396